Patient perspectives
Patient perspectives on chronic spontaneous urticaria
Arzoo Ahmed (Head of Ethics, Our Future Health, UK) and Elaine Dery (President, Canadian Patient Association; Global Allergy and Airways Patient Platform [GAAPP]) offer valuable insight on what it is like to live with chronic spontaneous urticaria (CSU).
Arzoo and Elaine discuss their treatment experiences, the importance of patient representatives at major congresses, such as GUF 2022, advice for physicians managing CSU, among other important topics. View their introductions here.
Global Allergy & Airways Patient Platform
A Shared Decision-Making Tool can help your Healthcare Provider learn more about where you are at with your CSU/CIU, and work with you to come up with or alter your management plan so that it meets your specific needs and goals.
Watch Global Urticaria Forum 2022 highlights
of interest
are looking at
saved
next event
CSU Resources and Managing CSU have been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
The industry-sponsored symposia and eLearning have been developed in collaboration with Novartis Pharma AG, with some content provided by Novartis Pharma AG. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Any data on non- Novartis products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country.